{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:39Z","timestamp":1791869079594,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ctrv.2016.11.016","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T22:20:03Z","timestamp":1482445203000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Splenic irradiation for splenomegaly: A systematic review"],"prefix":"10.1016","volume":"53","author":[{"given":"Nicholas G.","family":"Zaorsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor F.","family":"Esnaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Kropf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly B.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0005","first-page":"88","article-title":"Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients","volume":"169","author":"O'Reilly","year":"1998","journal-title":"West J Med"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5301\/tj.5000221","article-title":"Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders","volume":"101","author":"Sager","year":"2015","journal-title":"Tumori"},{"issue":"10","key":"10.1016\/j.ctrv.2016.11.016_b0015","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/bcj.2011.36","article-title":"How I treat splenomegaly in myelofibrosis","volume":"1","author":"Cervantes","year":"2011","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/bjs.9067","article-title":"Indications for and efficacy of splenectomy for haematological disorders","volume":"100","author":"Bickenbach","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctrv.2016.11.016_b0025","first-page":"281","article-title":"A case of spleno-medullary leukemia successfully treated by the use of the roentgen ray","volume":"63","author":"Senn","year":"1903","journal-title":"Med Rec"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2015.10.008","article-title":"What are medical students in the united states learning about radiation oncology? results of a multi-institutional survey","volume":"94","author":"Zaorsky","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0035","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/j.ijrobp.2012.01.058","article-title":"Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school","volume":"83","author":"Zaorsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.11.016_b0040","doi-asserted-by":"crossref","unstructured":"Hansen, EK. Roach, M. Handbook of evidence-based radiation oncology; 2010.","DOI":"10.1007\/978-0-387-92988-0"},{"issue":"10","key":"10.1016\/j.ctrv.2016.11.016_b0045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.ctrv.2016.11.016_b0050","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1002\/hed.23373","article-title":"Chondrosarcoma of the hyoid bone: case report and review of current management options","volume":"36","author":"Zhang","year":"2014","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00066-011-2252-4","article-title":"Radiotherapy of splenomegaly: a palliative treatment option for a benign phenomenon in malignant diseases","volume":"187","author":"Kriz","year":"2011","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000421-200304000-00016","article-title":"Palliative irradiation of the spleen","volume":"26","author":"McFarland","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2016.11.016_b0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ctrv.2013.01.008","article-title":"Systematic review of hypofractionated radiation therapy for prostate cancer","volume":"39","author":"Zaorsky","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.radonc.2015.05.011","article-title":"What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation","volume":"115","author":"Zaorsky","year":"2015","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0360-3016(89)90035-7","article-title":"A study of splenic irradiation in chronic lymphocytic leukemia","volume":"16","author":"Guiney","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/1607845414Y.0000000192","article-title":"Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma","volume":"20","author":"Ishibashi","year":"2015","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10428194.2011.614708","article-title":"Low dose palliative radiotherapy for splenomegaly in hematologic disorders","volume":"53","author":"Lavrenkov","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/104990919601300613","article-title":"Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders","volume":"13","author":"Paulino","year":"1996","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0095","first-page":"21","article-title":"Short-time splenic irradiation for splenomegaly","volume":"26","author":"Schratter-Sehn","year":"2003","journal-title":"Onkologie"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0100","first-page":"29","article-title":"Splenic irradiation in hematologic malignancies and other hematologic disorders\u2013single institution experience","volume":"50","author":"Soldic","year":"2011","journal-title":"Acta Clin Croat"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0105","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","article-title":"Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea","volume":"58","author":"Wagner","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2016.11.016_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000285","article-title":"Impact of radiation therapy dose escalation on prostate cancer outcomes and toxicities","author":"Zaorsky","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1586\/14737140.2013.836303","article-title":"Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?","volume":"14","author":"Zaorsky","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2016.11.016_b0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2016.06.006","article-title":"Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer","volume":"48","author":"Zaorsky","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"14","key":"10.1016\/j.ctrv.2016.11.016_b0130","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.18632\/oncotarget.7636","article-title":"Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.ctrv.2016.11.016_b0135","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.18632\/oncotarget.3704","article-title":"Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer","volume":"6","author":"Meng","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2012.10.003","article-title":"Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?","volume":"39","author":"Zaorsky","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajh.2830190210","article-title":"Spleen irradiation in chronic lymphocytic leukemia (CLL): palliation in patients unfit for splenectomy","volume":"19","author":"Aabo","year":"1985","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0145-2126(00)00018-7","article-title":"Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients","volume":"24","author":"Bouabdallah","year":"2000","journal-title":"Leuk Res"},{"issue":"11\u201312","key":"10.1016\/j.ctrv.2016.11.016_b0155","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0360-3016(77)90112-2","article-title":"Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics","volume":"2","author":"Parmentier","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0165","first-page":"1132","article-title":"Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience","volume":"20","author":"Pistevou-Gombaki","year":"2015","journal-title":"J BUON"},{"issue":"11","key":"10.1016\/j.ctrv.2016.11.016_b0170","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/1097-0142(19871201)60:11<2624::AID-CNCR2820601109>3.0.CO;2-F","article-title":"Splenic irradiation in chronic lymphocytic leukemia. A 10-year experience at a single institution","volume":"60","author":"Roncadin","year":"1987","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0175","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/10428190902898263","article-title":"Splenic irradiation in the management of Waldenstrom macroglobulinemia","volume":"50","author":"Davda","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.ctrv.2016.11.016_b0180","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(197506)35:6<1621::AID-CNCR2820350622>3.0.CO;2-U","article-title":"The role of splenic irradiation in chronic lymphocytic leukemia","volume":"35","author":"Byhardt","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lary.25444","article-title":"The role of radiation therapy in the management of sialorrhea: a systematic review","volume":"126","author":"Hawkey","year":"2016","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2014.10.002","article-title":"Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer","volume":"91","author":"Koshy","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.11.016_b0195","first-page":"145","article-title":"A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer","volume":"8","author":"Avkshtol","year":"2016","journal-title":"Res Rep Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clon.2004.12.003","article-title":"An audit of the indications for and techniques of palliative splenic radiotherapy in the UK","volume":"17","author":"Jyothirmayi","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctrv.2016.11.016_b0205","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10548","article-title":"Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2016.11.016_b0210","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","author":"Zaorsky","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/fon.14.123","article-title":"Pericytes: a double-edged sword in cancer therapy","volume":"11","author":"Meng","year":"2015","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.canlet.2016.02.033","article-title":"Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy","volume":"375","author":"Wang","year":"2016","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0225","first-page":"31","article-title":"Palliative spleen irradiation: can we standardize its technique?","volume":"20","author":"Nazmy","year":"2008","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1990.tb07889.x","article-title":"Splenic irradiation as primary therapy for prolymphocytic leukaemia","volume":"76","author":"Muncunill","year":"1990","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jjco\/28.4.267","article-title":"Splenic irradiation for prolymphocytic leukemia: is it preferable as an initial treatment or not?","volume":"28","author":"Yamamoto","year":"1998","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1440-1673.1997.tb00733.x","article-title":"Splenic irradiation for hairy cell leukaemia","volume":"41","author":"al-Moundhri","year":"1997","journal-title":"Australas Radiol"},{"issue":"2","key":"10.1016\/j.ctrv.2016.11.016_b0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000203984","article-title":"Hairy cell leukemia variant","volume":"94","author":"Dunn","year":"1995","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1016\/j.ctrv.2016.11.016_b0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1600-0609.2001.00537.x","article-title":"Successful treatment with low-dose splenic irradiation for massive splenomegaly in an elderly patient with hairy-cell leukemia","volume":"67","author":"Nishii","year":"2001","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.ctrv.2016.11.016_b0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000206690","article-title":"A role for splenic irradiation in the treatment of hairy-cell leukaemia. Case report and review of the literature","volume":"70","author":"Sharp","year":"1983","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.ctrv.2016.11.016_b0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00007611-198303000-00040","article-title":"Low-dose-rate irradiation in the treatment of hairy cell leukemia","volume":"76","author":"Weitberg","year":"1983","journal-title":"South Med J"},{"issue":"11\u201312","key":"10.1016\/j.ctrv.2016.11.016_b0265","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0360-3016(77)90113-4","article-title":"Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia","volume":"2","author":"Greenberger","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"159","key":"10.1016\/j.ctrv.2016.11.016_b0270","first-page":"97","article-title":"Radiotherapy for splenomegaly","volume":"44","author":"Mod","year":"2005","journal-title":"JNMA J Nepal Med Assoc"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737216301414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737216301414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T21:22:38Z","timestamp":1568668958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737216301414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":54,"alternative-id":["S0305737216301414"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.016","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenic irradiation for splenomegaly: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}